| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | General Counsel
1 company
Christine Ring is Chief Legal Officer at NRIX. From February 2021 to October 2026, the filings on record show 0 open-market purchases and 63 sales. Christine Ring's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $396K at current prices.
Our model assigns Christine Ring a strong insider score of 75/100, based on 59 past trades. Over a 12-month horizon, 86.0% of those trades were profitable, with an average 12-month return of +27.5%.
The NRIX filings lean toward selling, a net 304,318 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 1,200 | $27.20 | $32,640.00 | -59.9% | -10.2% | -50.0% | |
| Mar 10, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 2,000 | $41.27 | $82,539.36 | -71.3% | -28.4% | -68.3% | |
| Feb 18, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 2,000 | $35.88 | $71,750.35 | - | - | - |